Literature DB >> 20580794

Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres.

Ibrahim M El-Sherbiny1, Hugh D C Smyth.   

Abstract

Design of appropriate inhaled carriers with adequate aerodynamic properties, drug release, biodegradation and evasion of macrophage uptake is a major challenge for controlled release pulmonary drug delivery. In this study, PEG graft copolymerized onto N-phthaloyl chitosan (NPHCs) was synthesized then characterized using FTIR, EA, DSC and 2D-XRD. The resulting PEG-g-NPHCs copolymers were self-assembled into drug-loaded nanoparticles and encapsulated in respirable/swellable sodium alginate semi-IPN hydrogel microspheres as novel biodegradable carriers for controlled release pulmonary drug delivery. The developed nano-/microspheres carrier systems were formed via spray drying followed by ionotropic crosslinking in mild aqueous medium. The size of the developed self-assembled nanoparticles and the microspheres was measured using dynamic light scattering and laser diffraction, respectively. Morphology, moisture content, in vitro biodegradation and dynamic swelling studies were also investigated for the developed carriers. A model protein was entrapped and the in vitro release profiles were determined in PBS, pH 7.4 at 37 degrees C. A dry powder aerosolization study was conducted using a Next Generation Impactor (NGI). The developed microspheres had suitable aerodynamic diameters (1.02-2.63 microm) and an excellent fine particle fraction, FPF of 31.52%. The microspheres showed also a very fast initial swelling within the first 2 min and started to enzymatically degrade within the first 2h. Moreover, the microspheres entrapped up 90% of the model drug and showed promising in vitro sustained release profiles as compared to the control formulation. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580794      PMCID: PMC3654806          DOI: 10.1016/j.ijpharm.2010.05.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  21 in total

Review 1.  Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

Authors:  Fakhrul Ahsan; Isabel P Rivas; Mansoor A Khan; Ana I Torres Suarez
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

2.  Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.

Authors:  Zahoor Ahmad; A Zahoor; Sadhna Sharma; G K Khuller
Journal:  Int J Antimicrob Agents       Date:  2005-10       Impact factor: 5.283

Review 3.  Issues in drug delivery: concepts and practice.

Authors:  Ted B Martonen; Hugh D Smyth; Kristin K Isaacs; Ray T Burton
Journal:  Respir Care       Date:  2005-09       Impact factor: 2.258

4.  Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.

Authors:  Praneet Opanasopit; Tanasait Ngawhirunpat; Amornrut Chaidedgumjorn; Theerasak Rojanarata; Auayporn Apirakaramwong; Sasiprapha Phongying; Chantiga Choochottiros; Suwabun Chirachanchai
Journal:  Eur J Pharm Biopharm       Date:  2006-06-14       Impact factor: 5.571

5.  N-phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles.

Authors:  Praneet Opanasopit; Tanasait Ngawhirunpat; Theerasak Rojanarata; Chantiga Choochottiros; Suwabun Chirachanchai
Journal:  Eur J Pharm Sci       Date:  2007-01-19       Impact factor: 4.384

6.  Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.

Authors:  Jae Hyung Park; Seunglee Kwon; Minsu Lee; Hesson Chung; Ji-Hyun Kim; Yoo-Shin Kim; Rang-Woon Park; In-San Kim; Sang Bong Seo; Ick Chan Kwon; Seo Young Jeong
Journal:  Biomaterials       Date:  2006-01       Impact factor: 12.479

7.  Anticancer activity of mycobacterial DNA: effect of formulation as chitosan nanoparticles.

Authors:  M Kabbaj; N C Phillips
Journal:  J Drug Target       Date:  2001       Impact factor: 5.121

8.  Swellable microparticles as carriers for sustained pulmonary drug delivery.

Authors:  Ibrahim M El-Sherbiny; Shayna McGill; Hugh D C Smyth
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

9.  Release of dexamethasone from PLGA nanoparticles entrapped into dextran/poly(vinyl alcohol) hydrogels.

Authors:  Maria Grazia Cascone; Paola Maron Pot; Luigi Lazzeri; Zhouhai Zhu
Journal:  J Mater Sci Mater Med       Date:  2002-03       Impact factor: 3.896

10.  Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.

Authors:  Xinge Zhang; Huijie Zhang; Zhongming Wu; Zhen Wang; Haimei Niu; Chaoxing Li
Journal:  Eur J Pharm Biopharm       Date:  2007-08-16       Impact factor: 5.571

View more
  15 in total

1.  Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles.

Authors:  Ibrahim M El-Sherbiny; Hugh D C Smyth
Journal:  Mol Pharm       Date:  2011-12-28       Impact factor: 4.939

2.  Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.

Authors:  Nilesh Gupta; Hany M Ibrahim; Fakhrul Ahsan
Journal:  J Pharm Sci       Date:  2014-09-29       Impact factor: 3.534

Review 3.  Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.

Authors:  Sharad Mangal; Wei Gao; Tonglei Li; Qi Tony Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-05-01       Impact factor: 6.150

4.  Novel alginate based nanocomposite hydrogels with incorporated silver nanoparticles.

Authors:  Bojana Obradovic; Jasmina Stojkovska; Zeljka Jovanovic; Vesna Miskovic-Stankovic
Journal:  J Mater Sci Mater Med       Date:  2011-12-28       Impact factor: 3.896

5.  High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.

Authors:  Samantha A Meenach; Kimberly W Anderson; J Zach Hilt; Ronald C McGarry; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2014-08-20       Impact factor: 3.246

6.  Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy.

Authors:  A Sofia Silva; Kevin E Shopsowitz; Santiago Correa; Stephen W Morton; Erik C Dreaden; Teresa Casimiro; Ana Aguiar-Ricardo; Paula T Hammond
Journal:  Int J Pharm       Date:  2020-10-26       Impact factor: 5.875

Review 7.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.

Authors:  Anil Kumar; Fei Chen; Anbu Mozhi; Xu Zhang; Yuanyuan Zhao; Xiangdong Xue; Yanli Hao; Xiaoning Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

8.  Swellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery.

Authors:  Ju Du; Ibrahim M El-Sherbiny; Hugh D Smyth
Journal:  AAPS PharmSciTech       Date:  2014-07-31       Impact factor: 3.246

9.  Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.

Authors:  Mohanad Naji Sahib; Yusrida Darwis; Kok Khiang Peh; Shaymaa Abdalwahed Abdulameer; Yvonne Tze Fung Tan
Journal:  Int J Nanomedicine       Date:  2011-10-14

10.  Preparation and evaluation of enrofloxacin microspheres and tissue distribution in rats.

Authors:  Fan Yang; Jijun Kang; Fang Yang; Zhensheng Zhao; Tao Kong; Zhenling Zeng
Journal:  J Vet Sci       Date:  2015-01-30       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.